Zollinger-Ellison Syndrome with Multiple Endocrine Neoplasia Type 1 (MEN1)

Overview

Zollinger-Ellison Syndrome (ZES) is a rare condition where one or more tumors form in the pancreas or duodenum (the first part of the small intestine). These tumors, called gastrinomas, secrete large amounts of the hormone gastrin, which causes the stomach to produce too much acid. This leads to severe peptic ulcers and other digestive problems.

When ZES occurs as part of Multiple Endocrine Neoplasia Type 1 (MEN1), it is associated with tumors in other endocrine glands, such as the parathyroid and pituitary glands. MEN1 is an inherited disorder that increases the risk of developing tumors in multiple endocrine organs.

Prevalence: ZES is rare, affecting about 0.1 to 1% of people with peptic ulcers (NIH). Approximately 25-30% of ZES cases are linked to MEN1 (Cleveland Clinic). MEN1 itself affects about 1 in 30,000 people (Mayo Clinic).

Symptoms

Symptoms of ZES with MEN1 can vary but often include severe digestive issues due to excess stomach acid. Additional symptoms may arise from tumors in other endocrine glands.

Common Symptoms of ZES:

• Severe peptic ulcers: Painful sores in the stomach, duodenum, or esophagus that may not respond to typical ulcer treatments.
• Abdominal pain: Often severe and persistent, especially in the upper abdomen.
• Diarrhea: Frequent, watery stools due to excess stomach acid interfering with digestion.
• Acid reflux or heartburn: A burning sensation in the chest or throat.
• Nausea and vomiting: Sometimes with blood if ulcers are bleeding.
• Weight loss: Due to poor nutrient absorption and reduced appetite.
• Bleeding in the digestive tract: May lead to black, tarry stools or vomiting blood.

Additional Symptoms from MEN1:

• Hyperparathyroidism: High calcium levels (hypercalcemia) causing kidney stones, bone pain, or fatigue.
• Pituitary tumors: May lead to headaches, vision problems, or hormonal imbalances (e.g., prolactin excess causing milk production in non-pregnant women).
• Pancreatic tumors: Can cause low blood sugar (hypoglycemia) or other hormonal issues.

Causes and Risk Factors

Causes:

ZES is caused by gastrinomas, which are usually small tumors in the pancreas or duodenum. In MEN1, these tumors occur due to a mutation in the MEN1 gene, which is inherited in an autosomal dominant pattern (meaning a child has a 50% chance of inheriting the mutation if one parent carries it).

The MEN1 gene normally acts as a tumor suppressor. When mutated, it fails to regulate cell growth, leading to tumor formation in multiple endocrine glands.

Risk Factors:

• Family history: Having a parent or sibling with MEN1 significantly increases risk.
• Age: Symptoms often appear between ages 20 and 50, though they can develop earlier.
• Gender: MEN1 affects men and women equally, but women may experience symptoms related to pituitary tumors (e.g., prolactinomas) more frequently.

Diagnosis

Diagnosing ZES with MEN1 involves a combination of blood tests, imaging, and genetic testing.

Key Diagnostic Tests:

• Fasting gastrin blood test: High gastrin levels (often >1000 pg/mL) suggest ZES. The test may be repeated after a secretin stimulation test to confirm.
• Secretin stimulation test: Secretin is injected, and gastrin levels are measured. In ZES, gastrin levels rise significantly.
• Stomach acid measurement: A nasogastric tube may be used to measure acid levels in the stomach.
• Imaging tests:
  • Endoscopic ultrasound (EUS)
  • CT or MRI scans
  • Octreotide scan (a type of nuclear imaging)
• Genetic testing: Confirms MEN1 mutations in individuals or families with suspected hereditary cases.
• Screening for other MEN1-related tumors: Includes blood tests for calcium (parathyroid), prolactin (pituitary), and other hormones.

Treatment Options

Treatment aims to manage excess stomach acid, remove or shrink tumors, and address complications from MEN1.

Medications:

• Proton pump inhibitors (PPIs): High doses (e.g., omeprazole, pantoprazole) to reduce stomach acid and heal ulcers.
• H2 blockers: Alternative or adjunct therapy (e.g., famotidine) if PPIs are insufficient.
• Octreotide or lanreotide: Somatostatin analogs to reduce gastrin secretion in some cases.

Surgical and Procedural Options:

• Tumor removal: Surgery to remove gastrinomas if they are localized and not metastatic.
• Parathyroidectomy: Removal of overactive parathyroid glands in MEN1 patients with hyperparathyroidism.
• Pituitary tumor treatment: Surgery, radiation, or medication (e.g., cabergoline for prolactinomas).
• Liver-directed therapies: If tumors spread to the liver, options may include embolization, radiofrequency ablation, or chemotherapy.

Lifestyle and Supportive Care:

• Avoid foods that worsen acid reflux (e.g., spicy foods, caffeine, alcohol).
• Eat smaller, more frequent meals to reduce stomach acid production.
• Monitor calcium and vitamin D levels if hyperparathyroidism is present.
• Regular follow-ups with an endocrinologist and gastroenterologist.

Living with Zollinger-Ellison Syndrome with MEN1

Managing ZES with MEN1 requires lifelong monitoring and adherence to treatment plans. Here are some tips for daily management:

• Medication adherence: Take PPIs or other prescribed medications exactly as directed to control acid production.
• Dietary adjustments: Work with a dietitian to identify trigger foods and ensure adequate nutrition.
• Regular screenings: Undergo periodic imaging and blood tests to monitor tumor growth and hormone levels.
• Family planning: If you have MEN1, consider genetic counseling before having children.
• Support networks: Join patient support groups (e.g., MEN1.org) to connect with others facing similar challenges.

Prevention

Since ZES with MEN1 is often inherited, prevention focuses on early detection and management:

• Genetic testing: Family members of individuals with MEN1 should undergo genetic testing to identify carriers early.
• Regular screenings: Individuals with MEN1 should have annual blood tests and imaging to detect tumors early.
• Lifestyle choices: While lifestyle changes cannot prevent MEN1, avoiding smoking and excessive alcohol may reduce complications like ulcers.

Complications

If left untreated, ZES with MEN1 can lead to serious complications:

• Severe ulcers: May perforate the stomach or intestine, leading to life-threatening infections (peritonitis).
• Gastrointestinal bleeding: Can cause anemia or require emergency blood transfusions.
• Malnutrition: Chronic diarrhea and poor absorption can lead to weight loss and vitamin deficiencies.
• Metastatic tumors: Gastrinomas can spread to the liver or lymph nodes, becoming harder to treat.
• Endocrine crises: Tumors in the parathyroid or pituitary can cause dangerous imbalances in calcium or other hormones.

When to Seek Emergency Care

Sources and Further Reading

• Mayo Clinic
• Cleveland Clinic
• National Institutes of Health (NIH)
• Centers for Disease Control and Prevention (CDC)
• World Health Organization (WHO)